Bioglan Pharma, the UK pharmaceuticals group with a secondary listing on the Irish market, has acquired a portfolio of dermatology products for £16.4 million sterling (€26 million).
Bioglan Pharma, the UK pharmaceuticals group with a secondary listing on the Irish market, has acquired a portfolio of dermatology products for £16.4 million sterling (€26 million).